beta
/802P Nous-209 immunotherapy with pembrolizumab for microsatellite instability high (MSI-H) metastatic colorectal cancer, refractory to anti-PD-1: Phase II trial results
Abstract

Abstract N/A

RelatedView All
CitationsView All
Citing-
Cited By-